Condition

Acute Myelogenous Leukemia (AML) clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Nadunolimab plus azacitidine (± venetoclax) for high-risk MDS and relapsed/refractory AML

  This tests whether adding nadunolimab to azacitidine, with or without venetoclax, helps adults with high-risk MDS or relapsed/refractory AML get better responses and tolerate treatment.

  Recruiting Phase 1/2 M.D. Anderson Cancer Center · Houston, Texas · NCT06548230

• Transplant for Patients with Fanconi Anemia Using Adjusted Chemotherapy

  This study is testing a new way to use lower doses of chemotherapy before a stem cell transplant to see if it can safely help people with Fanconi anemia and serious blood disorders.

  Recruiting at 2 sites Phase 2 Children's Hospital Medical Center, Cincinnati · New York, New York and 2 other locations · NCT02143830

Related topics

Quick answers

How many Acute Myelogenous Leukemia (AML) clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →